| name | Calcium Hydroxylapatite Fillers |
| classification | Dental restorative material, biocompatible filler |
| pharmacokinetics | Not systemically absorbed; intended to remain local to the implantation site; no systemic absorption or distribution. |
| dosage | Implanted material quantity; not a medication to be taken orally or intravenously. |
| indications | Dental cavity filling, tooth structure restoration, bone augmentation, surgical procedures (bone regeneration), dental implantology. |
| safety in pregnancy | Limited clinical data; generally considered safe in dental procedures; consult a qualified healthcare professional. |
| safety in breastfeeding | Limited clinical data; generally considered safe; consult a qualified healthcare professional. |
| side effects | Generally minimal; potential local reactions (pain, swelling, infection at implantation site); rare long-term complications; allergic reactions possible (less common than with some other materials). |
| alternatives | |
| contraindications | | 1 | Hypersensitivity to calcium hydroxylapatite or other filler components | | 2 | Active or chronic infection at implantation site | | 3 | Conditions increasing risk of inflammation or adverse reactions |
|
| interactions | No significant drug-drug interactions anticipated (not systemically absorbed). |
| warnings and precautions | | 1 | Strict sterile technique during implantation | | 2 | Proper patient selection and evaluation of surgical site | | 3 | Strict adherence to post-operative care instructions | | 4 | Follow-up appointments crucial for monitoring complications |
|
| additional information | | 1 | Specific filler type, preparation, and additives may influence handling, implantation, and complications. | | 2 | Patient age, overall health, and medical history must be considered. | | 3 | Specific clinical context of need is crucial. |
|
